ArticleBMJ open2015
Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Article in BMJ open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Trial
- It depends on where you stand on screening: health professionals' awareness, perspectives, and approaches to overdiagnosis in cancer screening - a qualitative interview study.BMC health services research · 2026Article
- Prostate cancer screening in Europe: future directions and perspectives.Prostate cancer and prostatic diseases · 2026Review
- Article
- Lessons from the implementation of the Australian 2016 prostate specific antigen testing clinical practice guidelines: a descriptive study.ANZ journal of surgery · 2025Article
- Targeted prostate cancer screening using polygenic risk scores: lessons from the BARCODE1 trial.Translational andrology and urology · 2025Article
- Article
- Factors associated with patients' demand for low-value care: a scoping review.BMC health services research · 2024Article
- Review
- Point-of-Care Prostate Specific Antigen Testing: Examining Translational Progress toward Clinical Implementation.ACS sensors · 2023Review
- Article
- Article
- Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.Nature reviews. Urology · 2022Review
- Article
- Men's perception of information and descriptions of emotional strain in the diagnostic phase of prostate cancer-a qualitative individual interview study.Scandinavian journal of primary health care · 2021Article
- Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2021Article
- Why clinicians overtest: development of a thematic framework.BMC health services research · 2020Review
- A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020Article
- Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis.BMJ open · 2019Article
- Valuing Healthcare Improvement: Implicit Norms, Explicit Normativity, and Human Agency.Health care analysis : HCA : journal of health philosophy and policy · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectives(1) To explain general practitioners' (GPs') approaches to prostate-specific antigen (PSA) testing and overdiagnosis; (2) to explain how GPs reason about their PSA testing routines and (3) to explain how these routines influence GPs' personal experience as clinicians.
settingPrimary care practices in Australia including men's health clinics and rural practices with variable access to urology services.
participants32 urban and rural GPs within Australia. We included GPs of varying ages, gender (11 female), clinical experience and patient populations. All GPs interested in participating in the study were included. PRIMARY AND SECONDARY OUTCOME MEASURES: Data were analysed using grounded theory methods to determine how and why GPs provide (or do not provide) PSA testing to their asymptomatic male patients.
resultsWe observed patterned variation in GP practice, and identified four heuristics to describe GP preference for, and approaches to, PSA testing and overdiagnosis: (1) GPs who prioritised avoiding underdiagnosis, (2) GPs who weighed underdiagnosis and overdiagnosis case by case, (3) GPs who prioritised avoiding overdiagnosis and (4) GPs who did not engage with overdiagnosis at all. The heuristics guided GPs' Routine Practice (usual testing, communication and responses to patient request). The heuristics also reflected GPs' different Practice Rationales (drawing on experience, medicolegal obligations, guidelines and evidence) and produced different Practice Outcomes (GPs' experiences of the consequences of their PSA testing decisions). Some of these heuristics were more responsive to patient preferences than others.
conclusionsVariation in GPs' PSA testing practices is strongly related to their approach to overdiagnosis and underdiagnosis of prostate cancer. Men receive very different care depending on their GP's reasoning and practice preferences. Future policy to address overdiagnosis will be more likely to succeed if it responds to these patterned variations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.